Clinical Trial Update: Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine in HIV Positive, Asymptomatic and Symptomatic Individuals [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial assessed the safety and potential efficacy of combining polyethylene glycol–conjugated interleukin-2 (PEG IL-2) with zidovudine in HIV-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Pegylated interleukin-2 (polyethylene glycol-conjugated interleukin-2)
• RETROVIR (Zidovudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1 | Status: COMPLETED